
Starting from a position where only 5 percent of the medicines used in the country were produced in India in…
According to doctors and experts, NASH is an advanced form of non-alcoholic fatty liver disease (NAFLD) which is usually caused…
Meanwhile, speakers at this year’s event include Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at…
As per the terms of the definitive agreement, JB will take over the manufacturing, marketing and distribution of these brands…
It is essential to make an inclusive environment for industry experts and academicians to have a common platform for discussions…
Meanwhile, BioNTech also said that it was independently working on precision antibiotics that can kill “superbugs” that have grown resistant…
Oman has also requested India to consider negotiating a preferential trade agreement.
Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India Ltd said, “In order to enhance competitiveness on a global level,…
Kiran Mazumdar-Shaw, founder and executive chairperson of Biocon, said the deal will fast-track the company’s journey to build Biocon into…
Big pharmaceutical companies like Cipla, Sun Pharma and Dr. Reddy’s are set to release anti COVID-19 pill molnupiravir in the…
Jefferies India remains bullish on the Indian pharma companies, as it believes that Indian contract development and manufacturing companies are…
Speaking about the interest that has been generated in the pharmaceutical industry in the country, PM Modi also said that…
Analysts expect the near-term trend of Nifty to remain positive and see more upside in the coming sessions.
Macquaries sees Divi’s Laboratories and Syngene International as well placed in terms of growth, margin profile and return ratios
After moving 175% higher since the beginning of this year when it traded at Rs 427 per share, to now…
The Huntington’s disease pipeline will see exciting new developments over the next decade as disease-modifying drugs transform the market landscape,’…
Hemant Nerurkar will continues to be as the chairman MindCraft Software, a global software products, solutions and services organisation catering…
Abhijeet Das, Senior Associate, Singhania and Partners, opines that there are multiple fronts on which the aggrieved pharma companies can…